MGX vs MTB · rev $52.3M vs P/E 12, $30.99B cap
Metagenomi, Inc. Common Stock (MGX) versus M&T Bank Corporation (MTB) — a side-by-side from cached financials, not a winner call.
Metagenomi, Inc. Common Stock (MGX) is a biotechnology company listed on NASDAQ.
M&T Bank Corporation (MTB) is a banks - regional company listed on US.
Latest reported MGX revenue for 2024-12-31 was $52.3M. Net income was -$78.1M. Revenue was up 16.8% from 2023-12-31 to 2024-12-31. MGX currently screens at market cap $44.4M.
MTB does not have a complete income-statement cache yet.
MGX currently screens at market cap $44.4M. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
Not investment advice. Open the MGX and MTB stock pages for the full models.
Not investment advice.